Is Trending Stock Zoetis Inc. (ZTS) a Buy Now?

10:01am, Monday, 06'th May 2024
Zacks.com users have recently been watching Zoetis (ZTS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
NEW YORK , May 3, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zoetis Inc. (NYSE: ZTS)

Zoetis: Long-Term Buy Despite Safety Concerns

02:37pm, Friday, 03'rd May 2024
Zoetis is a leader in animal health, focusing on R&D to develop innovative medicines and technologies for pets and livestock. Concerns have arisen about the safety of their drugs, but Zoetis appears c
The SPDR S&P 500 ETF Trust had a 4.03% loss in April, slightly outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares, -4.13%.

Why Zoetis Stock Popped by Almost 6% on Thursday

04:56pm, Thursday, 02'nd May 2024
The animal health products purveyor unveiled its first-quarter results. It posted encouraging growth on both the top and bottom lines.

Zoetis CFO On The Pet Care Industry

02:08pm, Thursday, 02'nd May 2024
Zoetis CFO breaks down the pet advanced care industry.
Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares rise.

Zoetis Inc (ZTS) Q1 2024 Earnings Call Transcript

01:25pm, Thursday, 02'nd May 2024
Zoetis Inc (NYSE:ZTS ) Q1 2024 Results Conference Call May 2, 2024 8:30 AM ET Company Participants Steve Frank - Vice President of Investor Relations Kristin Peck - Chief Executive Officer Wetteny Jos

Zoetis CEO Kristin Peck on Q1 earnings

12:33pm, Thursday, 02'nd May 2024
Zoetis CEO Kristin Peck joins 'Money Movers' to discuss the company's quarterly earnings results, what the growth is attributable to, and what differentiates Zoetis from competitors.
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Zoetis (ZTS) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.31 per share a year ago.
Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets.

Zoetis Announces First Quarter 2024 Results

07:00am, Thursday, 02'nd May 2024
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024. The com
The animal health firm has had a tough year with shares down nearly 20% amid negative media reports about a key new medicine.
Fortune.com recently reported that artificial intelligence (AI) is helping the pet care industry cope with a chronic veterinary shortage. AI use cases could become far more prevalent for pets than hum
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE